DuraStat develops a surgical device that automates suture passage for dural repairs, significantly reducing procedure time and minimizing tissue disruption. This technology addresses the high incidence of incidental durotomy and cerebrospinal fluid leaks during spine surgeries, improving patient outcomes and lowering healthcare costs.
Funding
$9.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Incidental durotomy (ID), a common complication in spine surgery, occurs in approximately 10% of all procedures and up to 25% in lumbar revisions. Persistent cerebrospinal fluid (CSF) leaks, occurring in 9-21% of ID cases, can lead to poor patient outcomes and increased healthcare costs.
Solution
DuraStat is a surgical device designed to enable efficient and high-quality dural repairs, even in situations with limited access. The device automates suture passage with a button press, consolidating steps and eliminating supination. By facilitating optimal suture placement and minimizing tissue disruption, DuraStat helps surgeons gain control of the tear and create secure, sutured repairs, which are considered the gold standard for preventing persistent CSF leaks. The device's curved tip and internal needle and suture retention allow for precise pre-selection of needle placement.
Target Audience
The primary customers are clinicians, hospitals, and health systems focused on improving patient outcomes in spine surgery by reducing complications associated with dural repairs.
Features
- Automated suture passage via button-press mechanism
- Curved tip design for optimized access and control
- Integrated needle and suture retention for precise placement
- Facilitates sutured dural repairs to prevent CSF leaks
- Reduces procedure time by consolidating steps and eliminating supination
- Minimizes tissue disruption during suture placement